Clinical Trials Browser

Phase 2/3 × Unknown × Urinary Bladder Neoplasms × Clear all

NCT03427034 2018-02-09

ABSEIL

Phase 2/3 Unknown

Urinary Bladder Neoplasms, Hematuria, Recurrence